Valuation

P/E40.4
P/B2.2
P/S1.4
EV/EBIT23.1

Business Strength

ROE6.5%
ROCE11.1%
OPM8.4%
NPM2.8%

Growth (3Y CAGR)

EPS-5.0%
Sales+6.0%
Profit+8.0%
3Y Return+10.0%

Balance Sheet

Debt/Equity0.5
Debt35 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP-200.0%
FCF-7.26 Cr
FCF 3Y Avg-5.75 Cr
Cash/MCap5.0%

Others

Div Yield0.6%
Div Payout0.0%
Cash Conv. Cycle131 days
Tradeable Free Float43.5%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
--
+6.0%
--
--
--
Return
--
+14.0%
+10.0%
-20.0%
--
Decelerating
Sales
--
--
+6.0%
--
+3.0%
Decelerating
Profit
--
--
+8.0%
--
+2.0%
Decelerating

Quarterly Results

Mar 2026

10 Jun
Rev
50 Cr
+0% YoY-12% QoQ
OPM10.0%
NPM2.0%
PAT
--1 Cr
EPS
+25% YoY0.5

Sep 2025

PDF
Rev
57 Cr
+6% YoY+14% QoQ
OPM7.0%
NPM3.5%
PAT
--2 Cr
EPS
-12% YoY1.1

Mar 2025

PDF
Rev
50 Cr
-9% YoY-7% QoQ
OPM9.0%
NPM2.0%
PAT
--1 Cr
EPS
-18% YoY0.4

Sep 2024

PDF
Rev
54 Cr
-5% YoY-2% QoQ
OPM11.0%
NPM5.6%
PAT
--3 Cr
EPS
+14% YoY1.2

Mar 2024

PDF
Rev
55 Cr
+20% YoY-4% QoQ
OPM8.0%
NPM1.8%
PAT
--1 Cr
EPS
-25% YoY0.5

Sep 2023

PDF
Rev
57 Cr
+30% YoY+24% QoQ
OPM10.0%
NPM3.5%
PAT
--2 Cr
EPS
-33% YoY1.1

Mar 2023

PDF
Rev
46 Cr
--+5% QoQ
OPM9.0%
NPM2.2%
PAT
--1 Cr
EPS
--0.7

Sep 2022

PDF
Rev
44 Cr
----
OPM11.0%
NPM4.5%
PAT
--2 Cr
EPS
--1.6

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.52
Interest Coverage-18.0x
Promoter Pledge0.0%
Borrowings35 Cr

Efficiency

Receivable Days131 days
Inventory Days days
Payable Days days
Cash Conversion cycle131 days

Cash Position

Operating Cash Flow-6 Cr
Investing Cash Flow6 Cr
Financing Cash Flow1 Cr
Free Cash Flow-7 Cr

Detailed Financials

Mar 2026PDF ↗
Sep 2025PDF ↗
Mar 2025PDF ↗
Sep 2024PDF ↗
Mar 2024PDF ↗
Sep 2023PDF ↗
Mar 2023PDF ↗
Sep 2022PDF ↗
Sales5057505455574644
Expenses4553454851524240
Operating Profit54564545
OPM %10.0%7.0%9.0%11.0%8.0%10.0%9.0%11.0%
Other Income00100001
Interest33333333
Depreciation00000000
Profit Before Tax22232312
Tax %48.0%-49.0%49.0%24.0%36.0%27.0%-31.0%23.0%
Net Profit12131212
Exceptional Items----------------
EPS (Rs)0.51.10.41.20.51.10.71.6
Sales Growth (YoY)0.0%5.6%-9.1%-5.3%19.6%29.6%----
Sales Growth (QoQ)-12.3%14.0%-7.4%-1.8%-3.5%23.9%4.5%--
OP Growth (YoY)0.0%-33.3%25.0%20.0%0.0%0.0%----
OP Growth (QoQ)----------------
Profit Growth (YoY)----------------
EPS Growth (YoY)25.0%-12.2%-18.4%13.9%-24.6%-33.3%----
EPS Growth (QoQ)-53.7%170.0%-67.5%151.0%-54.6%66.2%-59.9%--
OP Margin10.0%7.0%10.0%11.1%7.3%8.8%8.7%11.4%
Net Margin2.0%3.5%2.0%5.6%1.8%3.5%2.2%4.5%
Material Cost %----------------
Employee Cost %52.0%51.0%48.0%47.0%49.0%45.0%45.0%43.0%
P/S1.381.32------------
P/E40.4441.15------------
P/B2.202.31------------

Shareholding Pattern

Shareholders:487 (+206.3%)
Current MixMar 2026

Annual Reports

6

2025

2024

2023

2022

2020

2019